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Abstract
Background: Preclinical and clinical evidence supports the concept of bidirectional brain-gut microbiome interactions.
We aimed to determine if subgroups of irritable bowel syndrome (IBS) subjects can be identified based on differences
in gut microbial composition, and if there are correlations between gut microbial measures and structural brain
signatures in IBS.
Methods: Behavioral measures, stool samples, and structural brain images were collected from 29 adult IBS and 23
healthy control subjects (HCs). 16S ribosomal RNA (rRNA) gene sequencing was used to profile stool microbial
communities, and various multivariate analysis approaches were used to quantitate microbial composition, abundance,
and diversity. The metagenomic content of samples was inferred from 16S rRNA gene sequence data using Phylogenetic
Investigation of Communities by Reconstruction of Unobserved States (PICRUSt). T1-weighted brain images were
acquired on a Siemens Allegra 3T scanner, and morphological measures were computed for 165 brain regions.
Results: Using unweighted Unifrac distances with hierarchical clustering on microbial data, samples were clustered into
two IBS subgroups within the IBS population (IBS1 (n= 13) and HC-like IBS (n = 16)) and HCs (n= 23) (AUROC = 0.96,
sensitivity 0.95, specificity 0.67). A Random Forest classifier provided further support for the differentiation of
IBS1 and HC groups. Microbes belonging to the genera Faecalibacterium, Blautia, and Bacteroides contributed
to this subclassification. Clinical features distinguishing the groups included a history of early life trauma and duration
of symptoms (greater in IBS1), but not self-reported bowel habits, anxiety, depression, or medication use. Gut microbial
composition correlated with structural measures of brain regions including sensory- and salience-related regions, and
with a history of early life trauma.
Conclusions: The results confirm previous reports of gut microbiome-based IBS subgroups and identify for the first
time brain structural alterations associated with these subgroups. They provide preliminary evidence for the
involvement of specific microbes and their predicted metabolites in these correlations.
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Background
Alterations in gut microbial composition or “dysbiosis”
have been implicated in the pathophysiology of irritable
bowel syndrome (IBS) [1–3]. IBS is the most common
chronic visceral pain syndrome. In the absence of agreed
upon biomarkers, the syndrome is defined by symptom
criteria which include the presence of chronically recur-
rent abdominal pain associated with alterations in bowel
habits [4]. This hypothesis has been based on the
reported findings of gut microbial differences between
healthy control subjects (HCs) and IBS patients, on find-
ings in rodent models of IBS, and on the theoretical
appeal of such a hypothesis to explain various clinical
observations. These include the observations in some
patients that antibiotic treatment can both trigger and
attenuate IBS symptoms [2], the development of IBS-like
symptoms following gastroenteritis in a small percentage
of patients [5], and the beneficial effects of the ferment-
able oligosaccharides, disaccharides, monosaccharides,
and polyols (FODMAP) elimination diet and probiotic
ingestion [2]. In addition, the well described interactions
between the gut microbiota with the brain and the gut-
based immune system provide plausible mechanisms
consistent with a role of altered gut microbiota in IBS
[6]. However, to date, few consistent differences have
been identified in the gut microbiota between HCs and
IBS. This may be in part related to the clinical (age, sex,
medications) and physiological (intestinal transit, history
of early adverse life events [EALs], stress reactivity)
heterogeneity of patients selected solely by symptom cri-
teria. One exception is an increased ratio between the
phyla Firmicutes and Bacteroidetes (F-B ratio) which has
been reported by several investigators [7–10]. A recent
study provided evidence for subgroups of IBS patients
based on gut microbial composition, which were inde-
pendent of predominant bowel habits and established
symptoms criteria [10].
There is a growing consensus that alterations in the
bidirectional interactions of the central nervous system
with the gut (brain-gut axis) play an important role in
IBS pathophysiology (reviewed in [6]). In animal models,
early adverse life events have been shown to be associ-
ated with stress-induced alterations in intestinal transit
(indexed by increased fecal pellet output, [11] and in the
composition of the gut microbiota [12, 13]. In addition
to a growing list of abnormalities described by different
investigators in the different components of the periph-
eral gut connectome [14, 15], both structural and func-
tional alterations of the brain have been identified in IBS
subjects [16]. Recent analyses have identified widespread
gray and white matter alterations in the brain of IBS
patients, including extensive changes in the somatosen-
sory system (thalamus, basal ganglia, S1, and M1). A
history of early adversity has also been shown to be
correlated with brain structural changes [17]. A recent
study showed cross sectional correlations between brain
structure and gut microbial composition [18]. The fact
that functional activity in some of the same regions
(somatosensory regions, basal ganglia) was increased
when healthy women consumed a probiotic mix over
4 weeks [19] suggests the possibility of a link between
gut microbial composition and sensory processing and
integration in the brain, both in healthy control subjects
(HCs) and in a subgroup of IBS patients.
By studying a group of well phenotyped IBS subjects
and HCs, we aimed to address three questions related to
gut microbiota, clinical parameters, and brain signatures:
1. Can gut microbial composition be used to classify IBS
patients and to identify subgroups with different clinical
and behavioral symptoms, as recently suggested? 2. Is
there an association between a history of early adverse
life events (EALs) and gut microbial composition? 3. Is
there a relationship between gut microbial composition
and IBS-related brain biomarkers? Based on past clinical
literature and brain regions altered in IBS, we expected
to see a relationship between microbiota and emotion-
related (amygdala, hippocampus) and sensory brain
regions (basal ganglia, posterior insula, and primary
sensory and motor regions).
Methods
Participants
Stool samples were collected at UCLA from 29 right-
handed adult IBS patients (22 females) and 23 HCs (14
females), who also underwent multimodal brain imaging
studies at UCLA. IBS subjects met Rome III symptom
criteria for IBS [20]. A gastroenterologist or nurse prac-
titioner obtained a medical history and physical exam to
confirm the IBS diagnosis. IBS patients with any bowel
habit were included. With regard to IBS diagnostic
subtypes, 11 subjects had IBS-constipation, 10 subjects
had IBS-diarrhea, and 8 subjects had either alternating
(1), mixed (5), or unspecified (2) bowel habits. The
Mini-International Neuropsychiatric Interview was used
to identify past or current psychiatric illness [21].
Exclusionary criteria for all subjects included (1) ser-
ious medical conditions or were taking medications
which could compromise interpretation of the brain
imaging; (2) ongoing major psychiatric diagnoses or use
of psychotropic medications in the past 6 months
(subjects were not excluded for lifetime incidence of
psychiatric disorders or for intake of low-dose tricyclic
antidepressants for non-psychiatric indications); (3) use
of antibiotics in the past 3 months, selective serotonin
reuptake inhibitors, opioids; and (4) excessive physical
exercise (e.g., marathon runners). All procedures com-
plied with the principles of the Declaration of Helsinki
and were approved by the Institutional Review Board at
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our institution. All authors had access to the study data
and reviewed and approved the final manuscript.
Questionnaires
The Hospital Anxiety and Depression Scale [HADs] [22]
and the Patient Health Questionnaire-15 [PHQ] were
obtained to assess mood [23]. The Early Traumatic
Inventory–Self Report (ETI-SR) [24] was used to access
histories of childhood traumatic and adverse life events
that occurred before the age of 18 years old and covers
four domains: general trauma (31 items), physical (9
items), emotional (7 items), and sexual abuse (15 items)
[24]. The Catastrophizing subscale from the Coping
Strategies Questionnaire was administered to assess
levels of catastrophizing [25]. The degree to which
subject viewed situations as stressful in the past month
was measured by the Perceived Stress Scale [26]. Medi-
cation usage was defined by endorsement of any of the
following: antispasmodic, laxatives, stool_softener, fiber
supplement, nonsteroidal anti-inflammatory drugs,
aspirin, acetaminophen, thyroid medications, antihista-
mine, or proton pump inhibitors.
A 1-month qualitative Food Frequency Questionnaire
(FFQ) from the third National Health and Nutrition
Examination Survey (NHANES III)1 was used to collect
information on participants’ eating patterns. The FFQ
data was processed using the National Cancer Institute’s
Diet*Calc software (Diet*Calc Analysis Program, Version
1.4.3. National Cancer Institute, Applied Research Pro-
gram. November 2005.), which provides estimates of
energy and nutrient intake [27]. A participant’s total
animal fat intake was calculated by summing the total
fat (in grams) of foods containing animal sources of fat
(Additional file 1: Table S1). Combination foods such as
soups and casseroles were excluded due to inability to
differentiate animal and plant fat sources. Using SPSS
(IBM Corp. Released 2013. IBM SPSS Statistics for
Windows, Version 22.0. Armonk, NY: IBM Corp.), the
mean intake of animal fat was calculated for each group
and compared across the three groups using univariate
analysis of variance.
Neuroimaging, segmentation, and parcellation
T1-weighted images were acquired on a Siemens Allegra
3 Tesla scanner, repetition time = 2200 ms, echo time =
2.85 s, inversion time = 750 ms, flip angle = 20°, field of
view = 220 × 220 mm, resolution = 256 × 256, slices per
volume = 176, slice thickness = 1 mm, voxel size = 0.86 ×
0.86 × 1 mm. T1-image segmentation and regional
parcellation were conducted using FreeSurfer [28–30]
following the nomenclature described in the Destrieux
and Harvard-Oxford subcortical atlas [31, 32]. For each
cerebral hemisphere, a set of 74 cortical structures were
labeled in addition to 7 subcortical structures and to the
cerebellum. One additional midline structure (the brain
stem) was also included, for a complete set of 165
parcellations for the entire brain. Four representative but
distinct morphological measures were computed for
each cortical parcellation: gray matter volume, surface
area, cortical thickness, and mean curvature. A list of all
the regions is provided in Additional file 2: Table S2.
Microbial analysis
Intestinal microbial composition: stool collection,
processing, and analysis of 16S rRNA gene sequencing data
Stool specimens were stored in an RNA stabilizing
reagent (RNALater) at −80 °C following collection at
UCLA. They were later placed in cryo-containers and
shipped to the Texas Children’s Microbiome Center.
Bacterial DNA from the self-collected stool specimens
was extracted, amplified, and sequenced, as previously
described.[9, 33–35] Briefly, 16S ribosomal RNA (rRNA)
gene sequence libraries were generated using the V3-V5
(357F/926R) primer region [9, 36] and sequenced on the
454 platform (Life Sciences, Branford, CT, USA). The
sequence libraries were parsed by barcode and quality
filtered using the Genboree Microbiome Toolset [35],
where sequences shorter than 200 bp, having average
quality scores <20, containing ambiguous base calls, or
including mismatches to barcode or sequencing primer
were culled. After quality filtering and the removal of
barcode and primer sequences, all remaining sequences
were clustered into operational taxonomic units (OTUs)
at a 97% similarity level using QIIME (Quantitative
Insights into Microbial Ecology, v1.3.0) [37]. OTUs were
clustered using the CD-Hit algorithm [38], and reads
were screened for chimeras using ChimeraSlayer [39].
All potential chimeras were excluded from further ana-
lysis. OTU identities were assigned using the Ribosomal
Database Project Classifier [40] with the Greengenes
reference database (version 12-10) and confidence scores
≥80%. To accommodate for variance in sequencing
depth, all sequence libraries were randomly sub-sampled
to a depth of 1355 sequences, the size of the smallest
quality filtered sequence library, prior to downstream
analysis. Bacterial community profiles were analyzed by
global parameters (described below) including determin-
ation of diversity, evenness, richness, and relative
abundance of the bacteria identified in each sample.
Output sequences were classified at the domain, phylum,
family, genus, and species levels where possible, depend-
ing on the depth of reliable classifier assignments [41].
Diversity analysis
Alpha-diversity metrics (i.e., bacterial diversity within a
sample) were computed and included Faith’s phylogen-
etic diversity metric, chao1 richness estimator, Shannon’s
entropy, and counts of observed OTUs [42, 43].
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Between-group differences in alpha diversity were evalu-
ated using a nonparametric t test, and 1000 Monte Carlo
permutations were used to calculate the nonparametric
p value. In addition, for each group, alpha-diversity
curves were generated for each diversity metric at differ-
ent rarefaction depths.
Determining relationships among samples
A phylogenetically informed distance matrix was com-
puted using the unweighted UniFrac metric [44].
Hierarchical clustering using average linkage was per-
formed to visualize relationships among the samples based
on similarity of microbial composition. As recommended
by Navas-Molina et al. [42], principal coordinate analysis
(PCoA) was used to evaluate the presence of clusters or
groupings in the data. PCoA provides information regard-
ing the largest source of variation in the data and allows
the observation of similarities and differences between
samples. Pearson correlations of OTU relative abundance
versus principal coordinate axis scores were used to
identify taxa contributing to the separation of samples in
PCoA space. PCoA indicated the presence of three groups
having similar microbial profiles, and these are labeled as
HCs, HC-like IBS, and IBS1 throughout the manuscript.
Adonis analysis, a permutational analysis of variance,
was performed to test for differences between groups in
overall microbial composition [45].
Random forest analysis was used to evaluate the degree
to which fecal communities could classify group and
identify features differentiating IBS microbial communities
from controls. The caret package (version 6.0-73) for R
[46] was used with repeated cross-validation (10-fold, five
repeats). Receiver-operating characteristic (ROC) curves
and area under the ROC (AUROC) were calculated using
the pROC package for R (version 1.8) [47]. Any OTU
occurring in fewer than 10% of subjects was filtered prior
to implementing the random forest algorithm.
Group differences in taxonomic abundance and clinical
metadata
Group differences in relative abundance at each
taxonomic level (phylum, class, order, family, genus, and
OTUs/“species”) and the ratio of Firmicutes to Bacteroi-
detes were tested using the nonparametric Kruskal Wallis
test correcting for multiple comparisons with the
Benjamini-Hochberg false discovery rate (FDR) procedure
and confirmed using pairwise comparisons. FDR cor-
rect p values (q) are reported. Independent sample t tests
were used to test for group differences in groups on symp-
tom severity, mood, and emotional trauma scores.
Association between brain structure and microbiota
Using Matlab, partial correlational analysis controlling
for total gray matter volume was used to examine the
association between the relative abundance of the phyla
Bacteroidetes and Firmicutes showing group differences
and all 165 brain volumes in IBS (n = 29). We also tested
for differences in the brain morphometry of somatosen-
sory-, motor-, and emotional-related regions between
the microbiota-derived clusters, IBS1, HC-like IBS, and
HC using contrast analysis within the framework of the
general linear model. Group was specified as a factor,
and total gray matter volume was specified as a covari-
ate. Somatosensory and motor regions included the basal
ganglia (putamen, caudate nucleus, nucleus accumbens,
globus pallidus), primary sensory (postcentral gyrus,
postcentral sulcus, central sulcus), secondary sensory
(subcentral gyrus (central operculum) and sulci), motor
(precentral gyrus, inferior part of the precentral sulcus,
superior part of the precentral sulcus), and mid and
posterior insula (long insular gyrus and central sulcus of
the insula, inferior segment of the circular sulcus of the
insula, posterior ramus of the lateral sulcus) regions.
Emotional-related regions included the amygdala and
the hippocampus. Analyses examining the relationship
between brain structure and microbiota analyses were
considered exploratory and important for future
hypotheses generation. We report uncorrected p
values as Type II error control and is equally import-
ant in exploratory research. We caution against
reliance on significance testing and instead emphasize
interpretation of effect sizes of brain-microbiota
associations for future studies.
Predicted metagenomics analysis
The metagenomic content of samples was inferred from
16S rRNA gene sequence data using PICRUSt 1.0 and
the KEGG database, which includes 6909 bacterial genes
(i.e., metagenes) annotated in reference genomes [48].
The data were filtered to remove metagenes present in
less than five samples or with an overall abundance less
than 10−6. Group differences in predicted metagenes
were identified using DESeq2 in R, which employs an
empirical Bayesian approach to shrink dispersion and fit
non-rarified count data to a negative binomial model
[49]. P values were adjusted for multiple hypothesis
testing using the Benjamini-Hochberg FDR procedure.
DESeq2 was also employed to identify metagenes with a
statistically significant association with brain struc-
tural features that differed among the three microbial
clusters. Selected metagenes associated with brain
morphometry and microbiome clusters were further
analyzed with FishTaco (http://borenstein-lab.githu-
b.io/fishtaco) [50]. This method uses a permutation
approach and Shapley value analysis to quantitate the
contribution of individual taxa to shifts in metagene abun-
dance between two clusters (https://borenstein-lab.github.io/
fishtaco/). Bioinformatics is available as Additional file 3.
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Results
Clinical characteristics
The means and standard deviation for descriptive data de-
scribing the samples can be found in Table 1. The average
ages for IBS (n = 29, females = 21) and HCs (n = 23,
females = 14) were similar, 26.1 years (SD = ±5.72 and
26.0 years (±6.5), respectively. Average symptom duration
in IBS subjects was 11.3 (±13.2) years. Even though IBS
subjects as a group had significantly greater level of
anxiety (p = .03) but not depression symptoms, the anxiety
levels for the majority of subjects were within the normal
range. However, six IBS subjects (HAD score range
12–17) and one HC (HAD score 13) had scores greater
than 11, indicating a probable level of clinical anxiety.
Compared to HCs, IBS reported greater levels of per-
ceived stress (p = .02) and higher levels of catastrophizing
(p = .02). No group differences were observed in total
emotional trauma history scores, but there was a trend for
a greater history of emotional trauma in IBS (p = .09).
Moderate to high levels of early life trauma (4–5) on the
emotional subscale were reported by 36% IBS subjects
while no healthy control subjects showed such scores. IBS
subjects reported average of overall symptoms in the past
week of 9.3 (±4.3) on a 21-point numeric rating scale (0 =
no pain, 20 = the most intense symptoms imaginable).
Distribution of bowel habit was 11 constipation (37.9%),
10 diarrhea (34.5%), 1 alternating (3.4%), 5 mixed (17.2%),
and 2 unspecified (6.9%].
No statistically significant differences in dietary
patterns were observed between groups. IBS1 showed
slightly higher BMI than HC-like IBS (p = .047) although
both groups had an average body weight within the
normal range.
IBS subgroup identified based on a microbiome signature
Hierarchical clustering using average linkage and PCoA
analysis on unweighted Unifrac distances are depicted in
Fig. 1a, b and Additional file 4: Figure S1. Together, these
analyses indicated that microbial signatures could be used
to group patients and to discriminate among samples.
Based on the PCOA and hierarchical clustering, the sam-
ples were labeled as IBS1 (IBS patients with microbial pro-
files distinct from HCs; n = 13), HC-like IBS (IBS patients
with similar microbial composition as HCs; n = 16) and
HCs (n = 23). One IBS subject clustered with IBS1 in the
PCoA but clustered with HCs in the hierarchical cluster-
ing. This subject was labeled as HC-like IBS subject. We
tested whether this group assignment changed group dif-
ference or correlation results but it did not. Adonis ana-
lysis [45] of the unweighted Unifrac distances indicated
that a significant proportion of the variance could be ex-
plained by IBS1–HC differences F(1,51) = 5.79, p = .004,
R2 = .10. The variance accounted for other group con-
trasts was not statistically significant (HC-like IBS-
IBS1, F(1,51) = 2.2, p = .073, R2 = .04; HC-like IBS-
HCs, F(1,51) = 1.23, p = .25, R2 = .02).
OTUs contributing to the variation in microbial signa-
tures along the 3rd axis of the PCoA plot (i.e., that
which captured the separation of the IBS1 communities
from the HC and HC-like IBS communities) were identi-
fied using correlation analysis. Those whose relative
abundances correlated most strongly with the location
along this axis are provided in Additional file 5: Table S3
and included members of the genera Faecalibacterium,
Bacteroides, and Blautia.
Random forest analysis provided further support for
the differentiation of IBS1 and HC groups. This analysis
Table 1 Group demographic and clinical characteristicsa
HC IBS
M SD N M SD N t p
Sex (% female)b 61% 23 72% 29 .55
Age 26.00 6.48 23 26.07 5.72 29 −0.04 .97
Body mass index 22.79 8.54 23 23.18 6.44 29 −0.18 .86
HAD anxiety 4.61 3.31 23 7.34 5.15 29 −2.21 .03
HAD depression 2.00 2.02 23 3.24 3.09 29 −1.66 .10
ETI_General_Scorec 1.57 (0–6) 1.53 23 2.00 (0–5) 1.69 27 −0.95 .35
ETI_Physical_Score 1.50 (0–5) 1.79 22 1.33 (0–4) 1.57 27 0.35 .73
ETI_Emotional_Score .41 (0–1) .908 22 1.19 (0–5) 1.90 27 −1.76 .09
ETI_Sexual_Score .26 (0–4) .915 23 .42 (0–5) 1.24 26 −0.52 .61
ETI_Total_Score 3.82 (0–15) 3.61 22 4.69 (0–17) 4.82 26 −.70 .49
Perceived stress score 12.73 7.04 22 17.39 7.08 28 −2.32 .02
Coping Scale Questionnaire .67 1.08 21 1.56 1.44 27 −2.34 .02
Abbreviations: HC healthy controls, IBS irritable bowel syndrome, M mean, P probability, SD standard deviation, t independent t statistic
aClinical characteristics for healthy controls and subjects with irritable bowel syndrome
bPercentage of female in each group, p value from Fisher’s exact test
cRange of scores in parentheses
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identified an OTU-based signature which correctly distin-
guished the majority of IBS1 subjects from HC subjects.
Using 10-fold cross-validation, the resulting model had an
AUROC of 0.96, sensitivity of 0.95, and specificity of 0.67
(Additional file 6: Figure S2). OTUs contributing to the
differentiation of IBS1 and HC gut communities, accord-
ing to their random forest importance (i.e., mean decrease
in accuracy) scores, included members of the genera
Blautia, Streptococcus, Faecalibacterium, and Bacteroides
(see Additional file 7: Table S4).
Diversity analyses and comparison of bacterial relative
abundances among IBS subgroups
Alpha diversity by groups (HC, IBS) and subgroups (IBS1,
HC-like IBS, HC) were calculated, and results are depicted
in Additional file 8: Figure S3. Comparison of Faith’s
phylogenetic diversity indices with nonparametric t tests
indicated that as a group, all IBS subjects (n = 29) showed
significantly greater diversity than HCs, t(50) = 2.83,
p = .007. Examining the IBS subgroups indicated this
was largely due to the fact that the IBS1 community
was more diverse than the HC-like IBS patients,
t(27) = 3.33, p = .012, and HCs, t(36) = 3.80, p = .003.
There were no differences observed between the
HC-like IBS subjects and HCs, t = .90, p = .99. Simi-
lar results were observed for the other diversity
measures: chao1 richness estimator, Shannon’s entropy,
and number of observed OTUs.
Figures 2 and 3 depict the microbial composition of
each group and individual at the phylum and class levels.
The ratio of Firmicutes to Bacteroidetes (F-B ratio) was
significantly higher in the IBS1 subgroup compared to
HCs (q = .02). The F-B ratio in the HC-like IBS group
did not differ significantly from either group (Fig. 4a).
The relative abundances of OTUs and the mean
relative abundance for identifiable taxa demonstrating
overall group differences at each taxonomic level
(phylum, class, order, family, and genus) are depicted in
Fig. 4. The means and standard deviations as well as
Kruskall Wallis tests of significance can be found for
identifiable and unidentified taxa and OTUs in
Additional file 9: Table S5.
At the phylum level (Fig. 4c), the relative abundance of
Firmicutes was significantly greater in the IBS1 subjects
compared to HCs (q = .002) but not the HC-like IBS
subjects (q = .075). On the other hand, the relative abun-
dance of Bacteroidetes was significantly lower in IBS1
group compared to HCs (q = .003) but not in the
HC-like IBS subjects (q = .12). For all comparisons, the
HC-like IBS group did not differ from the HCs with
respect to the relative abundance of either Firmicutes or
Bacteroidetes. Furthermore, no differences were ob-
served at the phylum level for the relative abundance of
Actinobacteria (IBS1 .1%, HC-like IBS 0%, and HCs 0%)
or Proteobacteria (1.3, .8, .4%).
At the class level (Fig. 4d), differences were observed
in the Firmicutes classes, Bacilli and Clostridia. The
relative abundance of members of Bacilli was greater
in IBS1 compared to HC-like IBS (q = .001) and HCs
(q = .005). For Clostridia, IBS1 showed greater abun-
dances than HCs (q = .004) but not HC-like IBS (q = .14).
IBS1 had lower abundances of Bacteroidetes class
Fig. 1 16s rRNA gene data revealed two distinct IBS subgroups, one indistinguishable from healthy controls. a Principal coordinate analysis (PCoA) on
the unweighted Unifrac distance matrix from the rarefied data was used to evaluate the presence of clusters or groupings based upon operational
taxonomic unit (OTU)-level microbial features. b Hierarchical clustering using average linkage was performed to visualize relationships among the
samples based on similarity of microbial composition. Both procedures operate on a phylogenetically informed distance matrix computed using the
unweighted UniFrac metric
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Bacteroidia compared to HCs (q = .002) but not HC-like
IBS (q = .075).
At the order level (Fig. 4e), differences were observed
with respect to the Bacilli order Lactobacillales with
greater abundance observed for IBS1 compared to HC-
Like IBS (q = .004) and HCs (q = .004). The relative
abundance of Bacteroidales order was lower in IBS1 com-
pared to HCs (q = .002) but not HC-like IBS (q = .075).
At the genus level (Fig. 4f ), members of the Erysipelo-
trichaceae genus Holdemania were more abundant
among IBS1 compared to HC-like IBS (q < .001) and
HCs (q < .001). Members of the Porphyromonadaceae
genus Parabacteroides were less abundant in IBS1
compared to HCs (q = .003) but not HC-like IBS (q = .097).
Mean differences in clinical metadata between IBS
subgroups based on microbial clusters
Detailed clinical data for the subgroups of IBS based on
microbial community profiles, IBS1 (9 females, 5 males)
and HC-like IBS (12 females, 3 males), are available in
Additional file 10: Table S6. IBS1 subjects reported a longer
duration of symptoms than HC-like IBS (t(26) = 2.80, p= .01)
as well as higher scores on the ETI emotional subscale, t(25)
= 3.14, p= .004. Although overweight status (BMI >25.0) was
not significantly different between the two IBS clusters, IBS1
[m(sd), 25.52 (5.68)] showed a trend (t(27) = 1,99, p= .057)
toward greater BMI compared to HC-like IBS [20.99 (6.51)],
Hedge’s effect size g (Cohen’s d corrected for small sample
sizes) = .74. This was associated with a trend for higher
dietary plant fat intake in the IBS1 group compared to HC-
like IBS (p= .047) and HC (p= .017).
In contrast, microbial community clustering in IBS was
not associated with sequencing depth, age, predominant
bowel habit, symptoms of anxiety or depression, levels of
catastrophizing, perceived stress, or medication usage.
Subgroup analysis in only females indicated that the
mean differences in the duration of symptoms, t(19) = 2.72,
p = .014, and emotional ETI scores remained significant as
did the trend for greater BMI (t(19) 1.80, p = .08 in IBS.
Associations between clinical metadata and microbiota
taxa differentiating IBS1 from HC-like IBS and HCs
Order level taxa
In IBS subjects, Lactobacillales, which had significantly
higher abundance in IBS1, had a moderately positive correl-
ation with ETI total score (r = .51, p = .008), as well as
sexual (r = .59, p = .001), physical (r = .51, p = .007), and
emotional (r = .42, p = .028) subscores. No correlations were
observed for Bacteroidales. Examining correlations in
female IBS only revealed that Bacteroidales positively corre-
lated with overall symptom severity (r = .423, p = .056).
Correlations with the ETI total score (r = .56, p = .01), and
its physical (r= .53, p = .013), emotional (r = .52, p = .02),
and sexual (r = .58, p = .008) subscores persisted.
Genus level taxa
Abundance of Parabacteroides was positively associated
with bloating r = .48 p = .03. Because Holdemania was
not identified in any group but IBS1, associations with
this genus were not examined.
Across all subjects (n = 48), the relative abundance of
the Firmicutes-associated class Bacilli was positively
Fig. 2 Microbial composition of each group at the phylum and class level. Pie charts show the proportion of reads in each phylum (top) and class
(bottom) for IBS1, HC-like IBS, and HCs
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correlated with ETI total score (r = .34, p = .018) as well
as with sexual (r = .43, p = .002) and emotional (r = .38,
p = .007) subscores. No correlations with EALs were
found for the Firmicutes-associated class Clostridia or
the Bacteroidetes-associated class Bacteroidia. IBS1 had
greater scores on the emotional scale of the ETI than
HC-like IBS (p = .004) and HCs (p = .001), while no
differences were observed between IBS and HCs as a
group for this score.
Association between brain structure and discriminative
microbiota in IBS subjects
Table 2 shows the results of the correlations between the
relative abundance of classes of bacteria associated with
Firmicutes and Bacteroidetes that discriminated the
microbial subgroups (Fig. 4d) and the parcellated 165 re-
gional brain volumes for all IBS (n = 29). Moderately
sized correlations were observed for the Clostridia
belonging to phylum Firmicutes (higher in IBS1), and for
the Bacteroidia belonging to phylum Bacteroidetes
(lower in IBS1) with several sensory integration regions
including the thalamus, basal ganglia (caudate nucleus,
putamen, pallidum, nucleus accumbens), and the super-
ior part of the precentral gyrus (motor cortex). Similar
correlations were found for the anterior insula and
ventral prefrontal regions.
Based on the relative abundance of these classes of
bacteria, volumes in the sensory brain regions were in-
creased, while volumes of insula and prefrontal cortices
were decreased in IBS1 compared to HC-like IBS. Very
few correlations were observed for the parietal, occipital,
and temporal regions. The abundance of the Bacilli
belonging to phylum Firmicutes showed correlations
with the volume of fewer regions including the nucleus
accumbens, prefrontal cortices, and ventral posterior
cingulate cortex.
As can be seen in Table 3, compared to HC-like IBS
and HCs, IBS1 had smaller cortical thickness and larger
surface area in the anterior insula. Compared to HC-like
IBS, IBS1 also showed greater volume and surface area
in the posterior insula, right globus pallidum, and lower
cortical thickness and surface area of motor cortex.
Finally, compared to HCs, IBS has greater volume in the
mid/posterior insula.
Fig. 3 Microbial composition of each sample by group at the phylum and class level. Stacked vertical bar charts depict the variability in phyla- and
class-level composition for individuals by groups
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Compared to HCs, HC-like IBS had greater cortical
thickness in the sensory brain regions, including the
left post central and central sulci and the right pos-
terior insula.
Metagenes enriched in the IBS1 subgroup are associated
with posterior insula morphometry
We investigated on an exploratory basis whether the
distinct microbial composition of IBS1 compared to HC-
IBS and HC was associated with a shift in the functional
profile of the microbiome. This was motivated by the
possibility that altered bacterial production of neuroac-
tive metabolites could contribute to the association of
microbial clusters with brain morphometric parameters.
Counts of bacterial genes (metagenes) were predicted
from the 16S rRNA gene sequence data using PICRUSt,
which imputes gene content for each OTU based upon
the phylogenetically closest reference genome. The
resulting count data were fitted to negative binomial
models using DESeq2 with microbial cluster as a
predictor. In pairwise comparisons, 606 metagenes (i.e.,
bacterial genes predicted by PICRUSt) differed in abun-
dance between the IBS1 subgroup and HC-IBS with
adjusted p value <.05 and 1223 metagenes differed
between IBS1 and HC. In contrast, there were no differ-
ential metagenes between HC-IBS and HC. In parallel
analyses, the same methodology was used to identify
metagenes associated with the 10 brain morphometric
parameters (each analyzed separately) that differed
among the three microbial clusters at p < .01 (Table 3).
Twenty-seven metagenes were found that were signifi-
cantly associated with both the IBS1 subgroup and with
brain morphometric parameters, including 20 that were
associated with the surface area of the right inferior
segment of the inferior segment of the circular sulcus
(a region of the posterior insula) (Additional file 11:
Fig. 4 Group differences in the relative abundance of microbiota. Bar graphs depict the Firmicutes to Bacteroidetes ratio (a), the mean relative
abundance for identifiable operational taxonomic units (b), and taxa demonstrating group differences at each taxonomic level (phylum, class, order,
family, and genus (c-f)). Error bars represent standard deviations
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Table S7). Of these, we focused on two metagenes
enriched in IBS1 that are involved in neurotransmitter
metabolism—4-hydroxybutyrate dehydrogenase, which
degrades γ-hydroxybutyric acid (GHB), and glutamate de-
hydrogenase, which mediates glutamate synthesis/break-
down—and on two metagenes enriched in IBS1 that are
involved in short chain fatty acid metabolism—acetate
co-A transferase subunit B, which mediates the final step
of butyrate synthesis, and propionate catabolism operon
regulatory protein, which regulates an operon of
propionate catabolism genes (Fig. 5a). The individual taxa
that made the greatest contribution to the association
of these metagenes with IBS1 were identified using
FishTaco. This highlighted a prominent role for one
particular taxon, an unclassified Peptostreptococca-
ceae, which had a trend toward significant correl-
ation (p = .058) with the right inferior segment of the
circular sulcus though it fell short of significance as
compared to the metagene encoding 4-hydroxybutyrate
dehydrogenase (p = .008) (Fig. 5b).
Table 2 Partial correlations between class-level taxa and brain regions controlling for total gray matter volume in IBS (N = 29)
Brain region Firmicutes-associated Bacilli Firmicutes-associated Clostridia Bacteroidetes-associated Bacteroidia
r p r p r p
Subcortical
L thalamus −.15 .461 −.40 .037 .36 .063
L caudate nucleus .28 .156 .49 .010 −.45 .017
L putamen .18 .376 .52 .006 −.53 .005
R putamen .11 .600 .42 .029 −.48 .012
L pallidum .30 .132 .37 .056 −.44 .023
R pallidum .35 .070 .36 .069 −.45 .019
L NACC .20 .326 .38 .052 −.45 .019
R NACC .42 .029 .53 .004 −.59 .001
R CeB −.20 .306 −.34 .080 .41 .032
Insula
Horizontal ramus of the anterior segment of
the lateral sulcus
.15 .462 −.42 .027 .35 .069
R short insular gyrus −.12 .535 −.51 .007 .44 .023
Vertical ramus of the anterior segment of
the lateral sulcus
−.20 .325 −.48 .012 .49 .009
Frontal
R Orbital part of the inferior frontal gyrus −.43 .025 −.43 .027 .49 .009
R orbital gyrus −.44 .020 −.39 .043 .47 .013
R gyrus rectus −.34 .083 −.47 .014 .46 .015
R superior part of the precentral gyrus −.23 .252 −.42 .031 .41 .033
L triangular part of the inferior frontal gyrus .46 .017 −.10 .604 .05 .790
Cingulate
Posterior-ventral part of the cingulate gyrus −.39 .043 −.11 .580 .07 .716
Parietal
R supramarginal gyrus .50 .008 .27 .167 −.28 .159
L_parietal occipital sulci .01 .969 −.50 .008 .45 .018
Temporal
L temporal pole −.39 .046 −.21 .284 .24 .228
L planum polare of the superior temporal gyrus −.07 .747 .41 .035 −.37 .060
L lateral occipital temporal sulcus −.02 .924 .45 .018 −.44 .021
Occipital
L superior and transvers occipital sulci .28 .153 .39 .043 −.45 .017
Pearson’s correlation between relative abundance and brain volumes
R=correlation, p=probability
P values less than .05 uncorrected are bolded
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Table 3 Brain morphometry differences based on microbiota profiles
IBS 1-HC-like IBS
Brain area Region of interest Brain measure p value β value Standard error
Somatosensory network
pINS Left posterior ramus of the lateral sulcus SA .002 60.73 18.47
pINS Right inferior segment of the circular sulcus of the insula SA .005 41.00 13.89
pINS Right inferior segment of the circular sulcus of the insula V .005 120.31 41.20
pINS Left posterior ramus of the lateral sulcus V .015 117.42 46.39
pINS Right long insular gyrus and central sulcus of the insula MC .045 −0.01 0.01
Basal ganglia Right globus pallidus V .007 102.28 36.47
Motor Left superior part of the precentral sulcus CT .009 −0.06 0.02
Motor Right superior part of the precentral sulcus V .006 −246.50 84.96
Motor Right superior part of the precentral sulcus SA .017 −96.24 39.02
Motor Right superior part of the precentral sulcus CT .026 −0.06 0.03
Motor Right subcentral gyrus (central operculum) and sulci CT .020 −0.08 0.03
aINS Left anterior segment of the circular sulcus of the insula CT .024 −0.09 0.04
aINS Right anterior segment of the circular sulcus of the insula CT .029 −0.13 0.06
aINS Right anterior segment of the circular sulcus of the insula SA .004 45.65 15.12
aINS Right anterior segment of the circular sulcus of the insula V .044 79.04 38.16
IBS1 - HC
pINS Left long insular gyrus and central sulcus of the insula V .009 81.33 30.10
pINS Left long insular gyrus and central sulcus of the insula SA .011 20.87 7.93
pINS Right superior segment of the circular sulcus of the insula CT .045 −0.05 0.02
pINS Left superior segment of the circular sulcus of the insula CT .042 −0.05 0.02
aINS Right anterior segment of the circular sulcus of the insula CT .003 −0.16 0.05
aINS Right anterior segment of the circular sulcus of the insula SA .002 43.67 13.51
Somatomotor Left central sulcus CT .043 0.04 0.02
Somatomotor Right central sulcus CT .033 0.04 0.02
HC-like IBS - HC
Somatosensory Left postcentral sulcus CT .005 0.06 0.02
Somatosensory Right postcentral sulcus CT .011 0.05 0.02
Somatomotor Right central sulcus CT .009 0.05 0.02
Somatomotor Left central sulcus CT .018 0.04 0.02
pINS Right inferior segment of the circular sulcus of the insula V .001 −122.97 35.48
pINS Right inferior segment of the circular sulcus of the insula SA .031 −28.23 12.75
pINS Right inferior segment of the circular sulcus of the insula CT .022 −0.07 0.03
pINS Left posterior insula gyrus CT .037 0.08 0.04
pINS Left long insular gyrus and central sulcus of the insula MC .035 0.01 0.01
pINS Right long insular gyrus and central sulcus of the insula MC .011 0.01 0.01
pINS Left posterior ramus of the lateral sulcus SA .034 −37.78 17.27
Basal ganglia Right nucleus accumbens V .029 −39.23 17.45
This table contains results of the contrast analysis within the framework of the general linear model. Contrast were coded based on the three level cluster factor;
IBS1-HC-like IBS (1 -1 0), IBS1-HC (1 0 -1), HC-like IBS-HC (0 1 -1). As such positive beta values indicate greater values in the first group listed. Negative values reflect
greater value in the second group
Abbreviations: INS anterior insula, pINS posterior insula, CT cortical thickness, SA surface area, V volume, MC mean curvature
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Discussion
This exploratory study aimed to identify possible corre-
lations between gut microbial community structure and
brain architecture. The main findings of the study were
(1) The identification of IBS subgroups based on distinct
microbial clusters with only one of these subgroups
(IBS1) showing gut microbial and some behavioral and
clinical differences; (2) The identification of differences
in the abundance of certain microbial taxa between IBS1
and HCs; and (3) The correlation of microbial taxa and
imputed metagenes with structural brain alterations pri-
marily in sensory integration and salience network
regions in IBS1. To our knowledge, this is the first
report demonstrating a correlation between the architec-
tures of the brain and the gut microbiota in a distinct sub-
group of IBS patients. These findings suggest a possible
influence of the gut microbiota and their metabolites on
specific brain structures which may play a role in the
pathophysiology of altered sensory processing in IBS.
Identification of IBS subgroups, based on microbiome
diversity and relative abundance of the phyla Firmicutes
and Bacteroidetes
Both hierarchical clustering using average linkage and
PCoA analysis on unweighted Unifrac distances indi-
cated that microbial signatures can be used to identify
Fig. 5 Bacterial genes involved in the metabolism of neurotransmitters and short-chain fatty acids correlate with the surface area of the right inferior
segment of the circular sulcus of the insula (R Inf Cir Ins). a Relative abundances in IBS1, HC-IBS, and HC are shown for four of the metagenes, e.g.,
genes predicted by PICRUSt associated with the surface area of the right inferior segment of the circular sulcus of the insula (R Inf Cir
Ins). Statistical significance was calculated using the Mann-Whitney U test; *p < .05, **p < .01. The contribution of individual taxa to the significance of
metagene differential abundance between IBS1 and HC was evaluated using FishTaco. The positive and negative effects of taxa on significance are
shown separately for taxa more abundant in IBS1 and those more abundant in HC. Taxa could influence significance either by carrying the predicted
gene (marked by an asterisks) or by being correlated with other taxa carrying the gene. “Other” refers to the total effect of all other taxa (out of 363)
included in the analysis. b Surface area of the R Inf Cir Ins is plotted against the relative abundances of K00043 and the Peptostreptococcaceae OTU
accounting for the majority of the predicted differential abundance of this metagene. Linear regression trendlines are shown along with the Pearson’s
correlation coefficient and p value
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two subgroups among the IBS subjects, one that has a
microbial composition similar to HCs, and one that
shows a distinct gut microbial signature. This differenti-
ation was also supported by our Random Forest classi-
fier. Identification of the subgroups was not associated
with sequencing depth. As a group, all IBS subjects
showed significantly greater alpha diversity and richness
than HCs, a difference that was largely explained by the
greater diversity within the IBS1 subgroup. Higher
alpha diversity has previously been reported in an IBS
subgroup [10], in patients with celiac disease [51],
and with autism spectrum disorder [52], all syn-
dromes which are often accompanied by IBS-like
symptoms. Even though an increased microbial diver-
sity has been associated with diets high in fruits, veg-
etables, and fiber [53], a detailed dietary analysis
between the groups did not reveal significant differ-
ences in dietary intake.
Subjects within the IBS1, but not the HC-like group,
differed from the HC group in the relative abundances
of the phyla Firmicutes and Bacteroidetes (F-B ratio).
While the abundance of Firmicutes was significantly
greater in IBS1, that of Bacteroidetes was lower. In con-
trast, the HC-like IBS group did not differ from the HC
with respect to these relative abundances. The finding of
gut microbiota-based IBS subgroups and some of their
gut microbial composition is similar to findings recently
reported by Jeffery et al. [10], even though they identi-
fied two IBS clusters that differed from HCs in addition
to a subgroup similar to HC. The finding of IBS
subgroups based on gut microbial composition that had
identical clinical symptoms suggests that the difference
in microbial architecture is either not necessary for
symptom generation in IBS, or that identical clinical
presentations can be caused by different underlying
mechanisms, one involving gut microbial alterations.
Similar to the current finding in the IBS1 subgroup, both
clusters in Jeffrey’s study showed a greater abundance of
Firmicutes and a lower abundance of Bacteroidetes.
Altered F-B ratios have been reported in other chronic
diseases [54], with increased F-B ratios reported in both
preclinical and clinical studies of obesity, metabolic syn-
drome, and high fat intake [55–57].
The reason for the increased F-B ratio found in this
and in previous studies in IBS subjects [8, 9] remains
unknown. F-B ratios in healthy individuals are highly
variable, despite similarities in microbial function [58].
However, age [59] and diet [55, 57, 60] are important
modulatory factors. For example, animal models of obes-
ity, obese individuals, those with metabolic syndrome,
and those on a Western diet with high animal fat
content were found to have increased F-B ratios [55–57].
Fatty acids in high fat diets, such as in the typical North
American diet, have been shown to increase the F-B ratio,
and this increase has been associated with an increase
in gut epithelial permeability and low grade inflam-
mation [61]. It is intriguing to speculate that the in-
creased F-B ratio in a subgroup of IBS patients is
related to alterations in epithelial permeability and
low grade inflammation which have been implicated
as possible disease mechanisms in IBS [62]. Even
though we observed trends for higher BMI and higher
plant-derived fat intake in the IBS1 group, these
differences did not reach statistical significance.
Specific dietary habits, such as increased consumption of
fat, have not been reported for IBS [63, 64]. No other
dietary differences between the groups were identified.
In addition to the differences in relative abundances at
the phylum level, several differences at lower taxonomic
levels were also observed. The IBS1 group showed a
greater relative abundance of several Firmicutes-related
taxa, including members of Bacilli and Clostridia at the
class level, of Bacilli-associated Lactobacillales at the
order level, and of Holdemania at the genus level. The
IBS-associated enrichment in Clostridia is particularly
interesting in light of the finding that select spore-
forming bacteria, dominated by Clostridia Cluster IV
and XIVa, sufficiently induce serotonin biosynthesis
by colonic enterochromaffin cells [65]. This aligns
well with the reported links between intestinal sero-
tonin dysregulation and IBS [66]. Holdemania are
commonly found in the healthy gut, but there are few
generalizable results for this genus. IBS1 differed in
these relative abundances from both HC-like IBS and
HCs, with the exception of differences in the
abundance of Lactobacillales, which were only seen in
comparison to HCs. This finding is surprising in view
of the common recommendation of probiotics to treat
IBS symptoms, the majority of which contain Lacto-
bacilli. As acute laboratory stressors have been shown
to decrease Lactobacilli in the stool in both clinical
and preclinical studies, one would expect a reduction
of Lactobacilli in a stress-sensitive disorder like IBS.
In addition to the increased abundance in some
microbes, the IBS1 group had lower relative abundances
of Bacteriodia at the class level, of Bacteroidales at the
order level, and of Parabacteriodes at the genus level.
All these differences were significant when compared to
the HC group, but not the HC-like IBS group. The
random forest analysis showed that OTUs contributing
to the differentiation of IBS1 from HC gut communities
included members of the genera Blautia, Streptococcus,
Faecalibacterium, and Bacteroides.
The reasons that the group differences in relative
abundance at lower taxonomic levels differed from those
reported by others [9, 10, 67] are unknown, but may
include differences in patient populations, diet, DNA
extraction techniques, and the primers used for
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amplicon generation, as well as differences with respect
to bioinformatic pipelines, data transformations, and the
statistical approaches applied to the data.
Correlation of gut microbial composition with behavioral
and clinical parameters
Similar to Jeffrey’s findings, we found few correlations
between the gut microbial-based subgroups and clinical
parameters such as IBS symptom severity, predominant
bowel habit, or medication use, except for a moderate
correlation with symptom duration. As subjective ratings
of predominant bowel habits generally show poor corre-
lations with colonic transit times, and the colonic transit
times are normal in the majority of IBS patients regard-
less of reported predominant bowel habit, the observed
lack of correlation of such ratings with microbial
composition is not surprising. As commonly observed in
clinical studies, IBS patients as a group had a signifi-
cantly higher level of anxiety symptoms while IBS1 and
HC-like IBS did not differ from each other. However, no
correlations between anxiety (or depression) symptom
scores and microbial parameters were observed.
Interestingly, IBS1 had significantly greater scores on
the emotional scale of the ETI than both the HC-like
IBS and HCs. While the relative abundance of the Firmi-
cutes-associated class Bacilli was positively correlated
with ETI total score, as well as with scores in the sexual
and emotional subscales of the ETI, no correlations with
EAL were found for the Firmicutes-associated class
Clostridia, or the Bacteriodetes-associated class Bacteroi-
dia. Even though the observed correlation between a his-
tory of ELAs and the microbiome needs to be confirmed
in future studies, one may speculate that brain driven
disturbances of the gut microbial environment in early life
[12] may have a long lasting effect on gut microbial
composition persisting throughout life, which in turn may
lead to further changes in brain structure/function.
Correlation with brain structures
Moderate-sized correlations with brain structure were
observed for certain Firmicutes- and Bacteroides-associ-
ated taxa. For example, the Firmicutes-associated
Clostridia (higher in IBS1) and the Bacteroidetes-associ-
ated Bacteroidia (lower in IBS1) showed correlations
with the volume of several subcortical brain regions in-
volved in sensory integration and modulation and the
motor cortex. For the majority of these regions,
increased volumes were observed with decreases in
Bacteroidia taxa and increases in the Clostridia taxa
characterizing IBS1. On the other, decreased volumes of
the anterior insula and ventral prefrontal regions were
associated with the taxa profile of IBS1. Whether
Clostridia-mediated modulation of peripheral serotonin
levels [65] may be involved is unclear, increasing
evidence reveals microbiome-mediated changes in neuro-
chemical signaling and neurophysiology. The abundance
of the Firmicutes-associated Bacilli (increased in IBS1)
was related to only a few regional brain volumes including
positive correlations with the right nucleus accumbens
and subregions of the frontal gyrus, and negative correla-
tions with other prefrontal cortices and the posterior
cingulate cortex.
Previous structural and white matter studies have
shown IBS-related alterations in some of the same
regions, with IBS patients showing larger gray matter
volumes [68] and altered white matter tracts in the thal-
amus and basal ganglia [69], and reduced gray matter
volumes in insula and prefrontal cortices [68]. Several
possible explanations for these structural brain changes
have been proposed, including genetic and epigenetic
factors, the effect of gut microbial metabolites, as well as
the effect of longstanding increased sensory signaling
from the periphery [6].
The biological mechanisms underlying the observed
correlations remain to be determined. For the sensory
brain regions, it is conceivable that neuroactive or proin-
flammatory metabolites generated by altered gut micro-
biota reach the brain, inducing neuroplastic changes. As
most patients with IBS symptoms have a longstanding
history of symptoms, often dating back to childhood, it
is likely that such altered gut microbiota to brain signal-
ing could have shaped the brain from early on in life.
This view is also consistent with the observed correl-
ation of microbial composition with EALs.
In support of this possibility, we found that the surface
area of the posterior insula was associated with the
predicted abundance of 20 bacterial genes increased in
the IBS1 group. The posterior insula is considered the
primary visceral cortex and was chosen a priori without
corrections for type I error. The identified genes
included two that influence synthesis/degradation of
GHB and glutamate. GHB is a neurotransmitter found
naturally at high levels in the intestine that inhibits in-
testinal peristalsis via GABAB receptors and has sedative
effects in the CNS [70, 71]. Glutamate is an excitatory
neurotransmitter in the enteric nervous system and in
the brain where it also plays an important role in synap-
tic plasticity [72]. The posterior insula was also associ-
ated with abundance of a subunit of butyryl-CoA:acetate
CoA-transferase, an enzyme used by intestinal bacteria
such as Faecalibacterium in the final step of butyrate
synthesis [73, 74]. Butyrate has histone deacetylase activ-
ity and signals through GRP43 and GRP109a (expressed
by enterochromaffin cells, vagal afferents, and micro-
glia), all potential mechanisms by which it could influ-
ence brain function or structure [75]. Interestingly, a
positive regulator of proprionate catabolism operon was
also associated with this region of the posterior insular,
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suggesting a shift in the short-chain fatty acid profile
[76]. Association of these metagenes with IBS1 group
was largely attributable to a single unclassified member
of the Peptostreptococcaceae. It is unclear why this taxon
bloomed in a subset of IBS patients, though diet or
fiber supplementation are possibilities [77]. Mechanis-
tic studies in rodent models are warranted to investi-
gate these hypotheses.
There are several limitations to this study. The sample
was relatively small and composed of both male and
female subjects and did not include measures of intes-
tinal transit times. Self-ratings of bowel habits are
known to have a poor correlation with intestinal transit
time. All correlations with brain structure were cross
sectional, and no conclusion about causality can be
made from our results. The observed gut microbial
changes could be secondary to altered autonomic
nervous system output to the gut, changing the micro-
bial environment [78]. Alternatively, the brain changes
could be the consequence of altered signaling to the
brain through microbial metabolites, or both mecha-
nisms may be involved [6]. Sequencing depth of the
microbiome may be a limitation as rare members of the
microbiota may be undetected, and differences in
sequencing depth may affect relative distributions of
microbial taxa. Finally, predicted metagenomics analysis
to impute potential metabolites involved in the observed
structural brain differences is limited, and results need
to be confirmed by metabolomics analyses.
Conclusions
In summary, this is to our knowledge the first report
demonstrating an association of gut microbial compos-
ition and function with regional brain structural changes
in IBS. Regardless of the causation underlying the
observed associations, several intriguing conclusions can
be made from this study. Both the correlations of
abundance of certain microbial taxa with early adverse
life events and with distinct brain structural changes
previously reported in IBS suggest a possible role of gut
microbes and their metabolites in the development and
shaping of the gut-microbiota-brain axis early in life.
Confirming results from a previous study [10], IBS
subgroups can be identified based on gut microbial com-
position, which do not correlate with clinical findings
such as bowel habits, or with psychological symptom
scores. These findings suggest the possibility of a new
classification of IBS patients based on gut microbial
signatures (and eventually on metabolomics profiles)
rather than on clinical characteristics. Furthermore, con-
sistent with clinical observations, the findings suggest
the possibility that treatments aimed at altered gut
microbial composition with antibiotics, probiotics, prebi-
otics, and certain diets may only work in subgroups of
patients with an altered gut microbiome. Not only could
such subgroups explain the lack of response to such
treatments in a significant proportion of patients but
also the worsening of IBS symptoms in subsets of pa-
tients with intake of food, fiber supplementation, and
even probiotics. Identifying IBS subgroups based on gut
microbiota, their related metabolomic profiles and corre-
sponding brain signatures is likely to play an important
role in optimizing therapies in IBS.
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